Ascentage Pharma and Tanner Pharma Group initiate a global innovative named Patient Program
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
Company raises the annual revenue guidance from mid-teens to high teens
Completion of the demerger of Haleon and share consolidation of GSK
ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers
Manish led SeQuent since 2014 and played a major role in transforming the company
Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs
Advancing to IND-enabling studies with multiple drug candidates
Orion to receive an upfront payment of USD 290 million
Subscribe To Our Newsletter & Stay Updated